Evaluating the updated LATE-NC staging criteria using data from NACC.

stages 1a–3 grouped), which showed a trend toward more frequent assessment with a phospho‐specific TDP‐43 antibody in those with LATE‐NC ( p = 0.072, chi‐square test).

also in 53,322 other papers